Published on 30/07/2021 4:19:41 PM | Source: Angel Broking Ltd

Quote on Sun pharma by Mr. Yash Gupta, Angel Broking Ltd

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel 

Download Telegram App before Joining the Channel

Below is quote on Sun pharma by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd   

Sun Pharmaceuticals reported a good set of numbers for Q1FY2022, posting revenue growth of 30% at ₹9669.4 crores in Q1FY2022 which is above the market expectations. The domestic market has done well for the company in this quarter up by 38.5%. We have seen strong growth reported by all the pharma companies on the back of a recovery in the acute therapeutic segment. We expect domestic growth momentum to continue in this financial year. US formulation market reported growth of 30% which is above the market expectations. The overall company reported one of the best quarterly results in a very long time. We have a positive outlook on Sun Pharmaceuticals Ltd.


Above views are of the author and not of the website kindly read disclaimer

betvakti elexusbet gorabet maksibet maltcasino milosbet quennbet setrabet atlantisbahis artoscasino dumanbet elitbahis fashionbet favoribahis hiltonbet liderbahis oslobet romabet vegabet yorkbet kalebet bet10bet bahislion bahislion bahislion betpark dakikbet dumanbet fenomenbet holiganbet kalebet kolaybet lordbahis olabahis onwin piabet pusulabet süper10bet vipbahis supertotobet mariobet bahigo bahis siteleri güvenilir bahis siteleri kaçak bahis siteleri betist 1xbet asyabahis betebet betgaranti betlike betvole ligobet pinbahis polobet verabet